JP2022552949A5 - - Google Patents

Info

Publication number
JP2022552949A5
JP2022552949A5 JP2022521201A JP2022521201A JP2022552949A5 JP 2022552949 A5 JP2022552949 A5 JP 2022552949A5 JP 2022521201 A JP2022521201 A JP 2022521201A JP 2022521201 A JP2022521201 A JP 2022521201A JP 2022552949 A5 JP2022552949 A5 JP 2022552949A5
Authority
JP
Japan
Prior art keywords
cells
binding site
csfr
icd
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022521201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552949A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051346 external-priority patent/WO2021068068A1/en
Publication of JP2022552949A publication Critical patent/JP2022552949A/ja
Publication of JP2022552949A5 publication Critical patent/JP2022552949A5/ja
Priority to JP2025131121A priority Critical patent/JP2025163198A/ja
Pending legal-status Critical Current

Links

JP2022521201A 2019-10-08 2020-10-08 キメラサイトカイン受容体 Pending JP2022552949A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025131121A JP2025163198A (ja) 2019-10-08 2025-08-06 キメラサイトカイン受容体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962912223P 2019-10-08 2019-10-08
US62/912,223 2019-10-08
PCT/CA2020/051346 WO2021068068A1 (en) 2019-10-08 2020-10-08 Chimeric cytokine receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025131121A Division JP2025163198A (ja) 2019-10-08 2025-08-06 キメラサイトカイン受容体

Publications (2)

Publication Number Publication Date
JP2022552949A JP2022552949A (ja) 2022-12-21
JP2022552949A5 true JP2022552949A5 (enExample) 2023-10-16

Family

ID=75436949

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521201A Pending JP2022552949A (ja) 2019-10-08 2020-10-08 キメラサイトカイン受容体
JP2025131121A Pending JP2025163198A (ja) 2019-10-08 2025-08-06 キメラサイトカイン受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025131121A Pending JP2025163198A (ja) 2019-10-08 2025-08-06 キメラサイトカイン受容体

Country Status (11)

Country Link
US (1) US20240122979A1 (enExample)
EP (1) EP4041893A4 (enExample)
JP (2) JP2022552949A (enExample)
KR (1) KR20220108768A (enExample)
CN (1) CN114929752A (enExample)
AU (1) AU2020362554A1 (enExample)
BR (1) BR112022006782A2 (enExample)
CA (1) CA3151472A1 (enExample)
IL (1) IL291282A (enExample)
MX (1) MX2022003885A (enExample)
WO (1) WO2021068068A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022254143A1 (en) * 2021-04-07 2023-11-23 Provincial Health Services Authority Modified granulocyte colony-stimulating factor (g-csf) and chimeric cytokine receptors binding same
WO2023192948A1 (en) * 2022-04-01 2023-10-05 Seattle Children's Hospital (dba Seattle Children's Research Institute) Chimeric cytokine receptors
EP4555072A1 (en) * 2022-07-11 2025-05-21 Sonoma Biotherapeutics, Inc. Recombinant cytokine receptors and methods of use
JP2025529913A (ja) * 2022-08-26 2025-09-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー キメラサイトカイン受容体及び使用方法
JP2026507228A (ja) 2023-03-03 2026-02-27 アーセナル バイオサイエンシズ インコーポレイテッド Ｐｓｍａ及びｃａ９を標的とするシステム
WO2026055342A1 (en) * 2024-09-04 2026-03-12 Arsenal Biosciences, Inc. Synthetic pathway activators
CN119912588B (zh) * 2025-04-01 2025-08-12 浙江大学 嵌合抗原受体、人诱导多能干细胞、髓系前体细胞样巨噬细胞及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022914A1 (en) * 1993-04-06 1994-10-13 Fred Hutchinson Cancer Research Center Chimeric cytokine receptors in lymphocytes
US6482927B1 (en) * 1995-11-27 2002-11-19 Millennium Pharmaceuticals, Inc. Chimeric proteins comprising the extracellular domain of murine Ob receptor
CA2530349A1 (en) * 2003-06-27 2005-01-06 Dnavec Research Inc. Method for transplanting lymphohematopoietic cells into mammal
WO2005072340A2 (en) * 2004-01-27 2005-08-11 Compugen Ltd. Novel polynucleotides encoding polypeptides and methods using same
EP1878745B1 (en) * 2005-04-22 2011-06-15 Keio University Humanin receptor or humanin-like polypeptide receptor
SI3300745T1 (sl) * 2013-02-15 2020-01-31 The Regents Of The University Of California Himerni antigenski receptor in postopki njihove uporabe
MX377283B (es) * 2013-11-21 2025-03-07 Ucl Business Ltd Célula t o nk que coexpresa un receptor antigénico quimérico (car).
US11072644B2 (en) * 2014-11-12 2021-07-27 Allogene Therapeutics, Inc. Inhibitory chimeric antigen receptors
WO2017180993A1 (en) * 2016-04-14 2017-10-19 Bluebird Bio, Inc. Salvage chimeric antigen receptor systems
US20190127435A1 (en) * 2016-04-20 2019-05-02 Fred Hutchinson Cancer Research Center Immunomodulatory il2r fusion proteins and uses thereof
EP3759132A1 (en) * 2018-03-02 2021-01-06 Allogene Therapeutics, Inc. Inducible chimeric cytokine receptors
AU2020362556A1 (en) * 2019-10-08 2022-05-12 Provincial Health Services Authority Modified extracellular domain of granulocyte colony-stimulating factor receptor (G-CSFR) and cytokines binding same

Similar Documents

Publication Publication Date Title
Akira The role of IL-18 in innate immunity
Lin et al. The common cytokine receptor γ chain family of cytokines
Zou et al. Functional characterisation of the recombinant tumor necrosis factors in rainbow trout, Oncorhynchus mykiss
Ciacci et al. Functional interleukin-2 receptors on intestinal epithelial cells.
Xu et al. Interleukin-17 and its expanding biological functions
Mantovani et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
Tominaga et al. IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells
Rose-John Interleukin-6 family cytokines
Lawless et al. Stat4 regulates multiple components of IFN-γ-inducing signaling pathways
Dinarello Targeting interleukin 18 with interleukin 18 binding protein
Gaffen Biology of recently discovered cytokines: interleukin-17–a unique inflammatory cytokine with roles in bone biology and arthritis
Yoshimoto et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production
Hoge et al. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling
Dickensheets et al. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes
Bird et al. Characterisation and expression analysis of interleukin 2 (IL-2) and IL-21 homologues in the Japanese pufferfish, Fugu rubripes, following their discovery by synteny
Feliciani et al. Keratinocytes and cytokine/growth factors
Hu et al. IL-17RC is required for IL-17A–and IL-17F–dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis
Szymański et al. Cytokines and apoptosis in atopic dermatitis
Chen et al. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel
US20080064096A1 (en) Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
Izuhara et al. IL-13: a promising therapeutic target for bronchial asthma
Asao et al. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation
JP2025163198A (ja) キメラサイトカイン受容体
Yoshikawa et al. TNF-α and IL-4 regulate expression of IL-13 receptor α2 on human fibroblasts
Sahoo et al. Interleukin and interleukin receptor diversity: role of alternative splicing